Metformin Inhibits Hepatic mTORC1 Signaling via Dose-Dependent Mechanisms Involving AMPK and the TSC Complex.
about
Assessment of metabolic and mitochondrial dynamics in CD4+ and CD8+ T cells in virologically suppressed HIV-positive individuals on combination antiretroviral therapy.Comprehensive Review on Colorectal Cancer and Transplant.Mitochondria in Cell Senescence: Is Mitophagy the Weakest Link?Regulation of hepatic glucose metabolism in health and disease.The mechanisms of action of metformin.AMPK: guardian of metabolism and mitochondrial homeostasis.Towards natural mimetics of metformin and rapamycin.SEC-induced activation of ANXA7 GTPase suppresses prostate cancer metastasis.Cytoprotective activated protein C averts Nlrp3 inflammasome-induced ischemia-reperfusion injury via mTORC1 inhibition.Drug repurposing for the treatment of glioblastoma multiforme.Metformin extends C. elegans lifespan through lysosomal pathway.Salinomycin, as an autophagy modulator-- a new avenue to anticancer: a review.A lipid off-switch for mTORC1.Metformin adapts its cellular effects to bioenergetic status in a model of metabolic dysfunction.Metformin induces autophagy and G0/G1 phase cell cycle arrest in myeloma by targeting the AMPK/mTORC1 and mTORC2 pathways.The effects of metformin on gut microbiota and the immune system as research frontiers.A Randomized Phase II Study of Metformin plus Paclitaxel/Carboplatin/Bevacizumab in Patients with Chemotherapy-Naïve Advanced or Metastatic Nonsquamous Non-Small Cell Lung Cancer.Metformin blocks MYC protein synthesis in colorectal cancer via mTOR-4EBP-eIF4E and MNK1-eIF4G-eIF4E signalingPleiotropic Effects of Metformin on Cancer
P2860
Q38635598-317C0C45-F4D1-4EAC-ACC1-6FB5E077425EQ38687757-A51985C0-20EE-4959-BF87-30821E0741D3Q38885570-FC15808F-E1DC-422C-B19F-7CC5F98A69B5Q39450184-02A74847-2882-4A3E-A416-9AEB25D3D1CBQ41353984-BADB9AB5-AECB-4A7D-9DEF-08F896056A1DQ45982416-792233A9-4FA4-4B75-8C35-8F9EAE96330DQ47140599-7A5AD7C8-055F-4B16-B313-DAFB7BB85F4DQ47243959-02ADA394-FD89-42D6-9963-30AF1DA12C46Q47350943-826797BE-B7E6-4F3C-9A7D-DF13A59AF5ACQ47948290-56089199-B003-4B42-A4F3-91826287164AQ48191171-3C2F8301-B243-4EA4-B34D-9E7A6CE77004Q50057844-EDA87DC9-F42F-4E90-BC0A-816E3467BB24Q50066309-7D9637A5-9AB6-4445-8628-25DBC515DC42Q52331745-34CE6BB4-F794-4451-8085-3271120533E9Q52350206-ADD13B7A-A48B-4B4B-942A-D9D8F157AB5AQ52552476-A90DF1F4-5ECB-4DBA-9D24-51FBDAA065C6Q52682466-F9CB984C-000F-45AE-B434-BAE416440B5CQ59137532-5B9F2278-262D-44F0-A9C7-59C2B81A1B71Q59138314-F2702AE4-9182-4D21-BA05-270F547023DD
P2860
Metformin Inhibits Hepatic mTORC1 Signaling via Dose-Dependent Mechanisms Involving AMPK and the TSC Complex.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Metformin Inhibits Hepatic mTO ...... ving AMPK and the TSC Complex.
@en
Metformin Inhibits Hepatic mTO ...... ving AMPK and the TSC Complex.
@nl
type
label
Metformin Inhibits Hepatic mTO ...... ving AMPK and the TSC Complex.
@en
Metformin Inhibits Hepatic mTO ...... ving AMPK and the TSC Complex.
@nl
prefLabel
Metformin Inhibits Hepatic mTO ...... ving AMPK and the TSC Complex.
@en
Metformin Inhibits Hepatic mTO ...... ving AMPK and the TSC Complex.
@nl
P2093
P2860
P1433
P1476
Metformin Inhibits Hepatic mTO ...... ving AMPK and the TSC Complex.
@en
P2093
Alan Saghatelian
Brendan D Manning
Debbie S Ross
George Talbott
Gerta Hoxhaj
Jessica J Howell
Kristina Hellberg
Marc Turner
Reuben J Shaw
P2860
P304
P356
10.1016/J.CMET.2016.12.009
P577
2016-12-30T00:00:00Z